CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0002 (42.86%)
Aug 18, 2025, 3:00 PM EDT
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $123.27 thousand as of August 18, 2025. Its market cap has decreased by -47.87% in one year.
Market Cap
123.27K
Enterprise Value
1.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has decreased from 238.06K to 123.27K, a decrease of -48.22%. That is a compound annual growth rate of -4.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 123.27K | -46.46% |
| Dec 31, 2024 | 230.22K | -47.89% |
| Dec 29, 2023 | 441.78K | -81.12% |
| Dec 30, 2022 | 2.34M | -79.95% |
| Dec 31, 2021 | 11.67M | -58.56% |
| Dec 31, 2020 | 28.16M | 71.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |